NCT03994263View on ClinicalTrials.gov

A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
BPH
Interventions
DEVICE

ITind device implant

device implanted for 5-7 days

Trial Locations (1)

Unknown

Kliniken Nordoberpfalz AG Klinik für Urologie, Kinderurologie und interdisziplinäres Prostatakarzinomzentrum, Weiden

Sponsors

Lead Sponsor

Medi-Tate Ltd.
All Listed Sponsors
lead

Medi-Tate Ltd.

INDUSTRY

NCT03994263 - A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI | Biotech Hunter | Biotech Hunter